SBLOB

#calico

πŸ†•
www.calicolabs.com 27/06/2026

Calico Life Sciences Announces Fosigotifator Granted Breakthrough Therapy Designation by the U.S. FDA for the Treatment of Vanishing White Matter Disease - Calico

South San Francisco, Calif., June 23, 2026 – Calico Life Sciences LLC (Calico), a clinical-stage biotechnology organization focused on aging and age-related diseases ...
#biotechnology organization focused #calico sciences #aging age related
Leggi su www.calicolabs.com
f 𝕏 in πŸ“±
πŸ†•
www.calicolabs.com 13/06/2026

Calico Life Sciences Announces U.S. FDA Fast Track Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease - Calico

South San Francisco, Calif., October 2, 2025 – Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and ...
#biotechnology organization focused #autosomal dominant polycystic #calico biotechnology organization
Leggi su www.calicolabs.com
f 𝕏 in πŸ“±
πŸ†•
www.calicolabs.com 13/06/2026

Calico Life Sciences Announces U.S. FDA Orphan Drug Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease - Calico

South San Francisco, Calif., November 5, 2025 – Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and ...
#biotechnology organization focused #autosomal dominant polycystic #calico biotechnology organization
Leggi su www.calicolabs.com
f 𝕏 in πŸ“±